Current evaluations, such as the Organized Prostate Cancer Testing project, are underway in most regions of Sweden, seeking to implement and assess the value of organised testing that combines PSA, MRI, and biopsies using specific algorithms [29]. This evidence concerns the gene KLK3 and Familial prostate cancer.